THE ROLE OF PREOPERATIVE CARCINOEMBRYONIC ANTIGEN IN RECURRENCE OF RESECTABLE COLORECTAL CARCINOMA/ULOGA PRIJEOPERACIJSKOG KARCINOEMBRIJSKOG ANTIGENA U RECIDIVIRANJU RESEKTABILNOG KOLOREKTALNOG KARCINOMA

In colorectal carcinoma, carcinoembryonic antigen (CEA) is a recommended marker for surveillance after curative resection. The aim of the present study was to determine the association of preoperative CEA with recurrence of colorectal carcinoma in our population. The study included 55 patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta clinica Croatica (Tisak) 2020-06, Vol.59 (2), p.216
Hauptverfasser: Kha, Madiha Ali, Maken, Rab Nawaz, Nisar, Hasan, Fatima, Ismat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In colorectal carcinoma, carcinoembryonic antigen (CEA) is a recommended marker for surveillance after curative resection. The aim of the present study was to determine the association of preoperative CEA with recurrence of colorectal carcinoma in our population. The study included 55 patients with all operable stages of colorectal adenocarcinoma treated during the 2012-2014 period, evaluated retrospectively and followed-up for recurrence for 2 years. Data on the baseline (preoperative) CEA levels were retrieved from patient files. On data analysis, SPSS 16.0 was used. In patients with normal preoperative CEA, the rate of recurrence was significantly low (p=0.008) and the likelihood of no recurrence 1.55-fold greater as compared to patients with raised initial CEA levels (p=0.028). In patients with raised preoperative CEA, the risk of recurrence was 5.26-fold greater as compared to those with normal CEA levels (p=0.028). A significant weak positive correlation ([r.sub.s] =0.297) was found between raised CEA and recurrence. A highly significant (p=0.002) moderate positive correlation was recorded in patients aged
ISSN:0353-9466
DOI:10.20471/acc.2020.59.02.03